Leishmaniases are diseases caused by protozoa of the genus *Leishmania*. Human infection occurs through the bite of an infected sandfly and it is estimated that approximately two million new cases of leishmaniasis occur each year; however, only approximately 600,000 are reported ([@B4]). In Brazil, cases are reported for all regions and leishmaniasis is especially common in the states of Ceará, Maranhão and Bahia ([@B27]).

Leishmaniasis can manifest as a tegumentary form that includes cutaneous and mucocutaneous leishmaniasis or as a visceral form of the disease. The difference in clinical manifestation depends on the host immune system and the infecting parasite strain ([@B44]). The most common clinical form of tegumentary leishmaniasis (TL) is cutaneous leishmaniasis (CL). CL is characterised by a single ulcer, which is also referred to as localised CL (LCL) and this ulcer may spontaneously regress or disseminate into the multiple ulcers and papules, which are characteristic of disseminated leishmaniasis (DL), an emerging form of leishmaniasis ([@B10], [@B37]). Multiple studies of the morphological pathology of leishmaniasis have been performed in attempts to establish a morphological pattern that could be used to differentiate between the lesions ([@B5], [@B33], [@B23]).

In infected individuals who do not develop lesions or disease, the immune response expresses a T-helper (Th)1 pattern that can be detected in peripheral blood cells ([@B9]). However, the intensity of inflammation can also result in ulcerations in which the healing capacity of these cells is lost, thus favouring the immunopathology of the disease ([@B18]).

In LCL, the lesions involve a local inflammatory reaction composed primarily of plasma cells, macrophages and lymphocytes. Experimental studies have evaluated T lymphocytes and their contributions to the lesion resolution process and to resistance to infection ([@B28], [@B26], [@B35]). In humans, several studies have evaluated the frequency and the pattern of T cells in the peripheral blood and tissues from TL ([@B38], [@B8], [@B14], [@B15], [@B3], [@B6]).

One study suggested that the humoral response was not essential for the development of protective immunity in human leishmaniasis ([@B24]). However, studies in experimental models have shown that B cell depletion leads to disease exacerbation, suggesting that B cells are necessary for the activity of the T cells that mediate lesion healing; thus, humoral responses may in fact play a role in mediating protective immunity against leishmaniasis ([@B36]). Comparisons of the immune responses involved in LCL and DL have indicated that the host immunity in LCL is more efficient, with higher production of interferon (IFN)-γ and tumour necrosis factor ([@B37], [@B19]).

The differences in the immune responses between the localised and disseminated forms may provide information regarding protection and resistance against leishmaniasis parasites. The present study used histopathology and the detection of cells *in situ* to examine the differences between the two clinical forms of leishmaniasis. Correlations between cell populations and the total extent of inflammation may highlight aspects of the tissue response and elucidate leishmaniasis pathogenesis. Thus, the present study aimed to compare the histopathology and cell infiltrates in biopsies from patients with early and late LCL and from patients with DL who presented both ulcers and papules.

SUBJECTS, MATERIALS AND METHODS
===============================

*Patients characteristics* - We evaluated 30 patients divided into the following four groups: 10 patients with skin lesions diagnosed with recent LCL (LCL-E) (within 20 days after the appearance of the first lesion), 10 patients with late LCL (LCL-L) (lesions for more than 30 days) and 10 patients with DL who had both ulcers (DL-U) and papules (DL-P), resulting in two biopsies per patient in this group. Biopsies were performed for diagnosis and selected according to the clinical criteria specified above. The analysed variables were obtained from medical records.

Leishmaniasis was diagnosed in subjects depending on clinical criteria, positivity for Montenegro intradermal skin test, parasite culture, polymerase chain reaction and histopathology. Grocott staining was used for fungal differential diagnosis and immunohistochemistry (IHC) using a polyclonal anti-*Leishmania* antibody was performed for confirmation when necessary.

*Biopsy: procedure, processing and analysis* - Skin fragments obtained from the borders of ulcers or papules were performed using a 4-mm "punch" while the patient was under local anaesthesia. The fragments were fixed in 10% formalin for 48 h and processed at the histotechnology laboratory at Oswaldo Cruz Foundation (Fiocruz). After paraffin embedding, the tissues were cut into 5-μm sections for staining with haematoxylin and eosin (H&E) and for IHC.

*Immunohistochemical staining* - The tissue sections obtained from paraffin were deparaffinised and rehydrated. IHC reactions were performed after blocking peroxidase activity with 3% hydrogen peroxide for 5 min. The slides were incubated at 25ºC with anti-*CD4*(M3354, Spring, USA), anti-CD68 (M071801-5, DAKO, USA) or anti-CD20 (Mob 004, DBS) antibodies at dilutions of 1:500, 1:50 and 1:50, respectively. A Peroxidase Mouse & Rabbit Kit/HRP (DBS KP500, USA) was used to perform the reaction according to the manufacturer's recommendations. All of the slides were counter-stained with Harris haematoxylin, dehydrated and mounted with Canadian balsam and glass coverslips.

*Cellular composition analysis* - A Nikon ACT-1 with v.2.70 software was used to capture 15 random images from 15 different fields of each tissue sample at 400X magnification. The quantification of CD4^+^, CD20^+^ and CD68^+^ cells was performed manually using ImageJ software (National Institutes of Health). Neutrophils and plasma cells were directly quantified from fragments stained with H&E following the same methodology. The numbers of cells were reported as absolute values (number of cells/15 fields).

*Inflammation quantification* - Images of tissue fragments stained by H&E were captured as described. The analysis was performed on the total area of the tissue fragment and the extent of inflammation (μm^2^) was determined using ImageJ software. The percentage of inflammation/fragment total area was determined.

*Histopathological analysis* - Histopathological analysis was performed by two observers on all of the fragments stained with H&E. The morphological characteristics of each biopsy were evaluated for their presence (+) or absence (0) and reported in a worksheet. Changes were observed in the epidermis (fibrin crust, hyperkeratosis, acanthosis, hydropic degeneration, spongiosis and exocytosis) and in the dermis (oedema, granulation tissue, granulomas, giant cells and lytic necrosis).

*Ethical considerations* - The study was approved by the Human Ethical Committee of the Gonçalo Moniz Research Center under Fiocruz protocol 321-2009.

*Statistical analysis* - Statistical analyses were performed using GraphPad Prism 5.0. Spearman correlation analysis, Kruskal-Wallis and Pearson correlations and One-Way ANOVA were performed as non-parametric and parametric tests, respectively. The results were considered statistically significant when p \< 0.05. A chi-square test was performed to compare the frequencies between variables in independent samples.

RESULTS
=======

Twenty patients with LCL were placed in the following subgroups according to the duration of their lesions: LCL-L, for those with lesions with more than 30 days and LCL-E, when diagnosed with an ulcer for less than 20 days. The other 10 patients had DL and all of these patients had simultaneous ulcerated primary lesions (DL-U) plus secondary lesions due to dissemination (DL-P), thereby forming a fourth group composed of the same patients. The clinical characteristics of the patients are described in [Table I](#t01){ref-type="table"}.

TABLE IClinical characteristics of patients with cutaneous leishmaniasis (CL)CharacteristicsLCL-L (n = 10)LCL-E (n = 10)DL-U (n = 10)DL-P (n = 10)Male:female07:0307:0307:0307:03Age (mean years ± SD)25 ± 1123 ± 945 ± 1745 ± 17Lesion duration (mean days ± SD)34 ± 1017 ± 243 ± 2030 ± 25Number of lesions (mean days ± SD)113 ± 429 ± 60Lesion size (mean mm^2^ ± SD)337 ± 24058 ± 63185 ± 136NMMST (mean mm^2^ ± SD)190 ± 125322 ± 256164.6 ± 136164.6 ± 136[^1]

The epidermis and dermis were analysed separately. The analysed histopathological-characteristic frequencies and the comparisons between the groups are described in [Table II](#t02){ref-type="table"}.

TABLE IIFrequency of histopathological aspects observed in the 40 cutaneous leishmaniasis (CL) and disseminated leishmaniasis (DL) biopsiesEpidermisDermisFibrin crustHyperkeratosisAcanthosisHydropic degenerationSpongiosisExocytosisOedemaGranulation tissueGranulomaGiant cellsLytic necrosisLCL-L30801008080509090802050LCL-E309010080506010090302010DL-U090107080501010202050DL-P4070705050501010303050p  LCL-L x LCL-ENSNSNSNS0.0001NSNSNS0.0001NS0.0001  LCL-L x DL-U0.0001NSNSNSNSNS0.00150.00150.0001NSNS  DL-U x DL-P0.00010.00070.00010.00590.0001NSNSNSNSNSNS[^2]

Biopsies from the LCL-E and LCL-L patients presented similar morphological characteristics in the epidermis and dermis. In the LCL-E group, a fibrin crust was observed in 30% of the cases, hyperkeratosis in 90%, acanthosis in 100%, hydropic degeneration in 80% and exocytosis in 60%. In the dermis, granulation tissue was present in 90% of the cases and giant cells were present in 20% of the cases. However, unlike early ulcers, late lesions had more spongiosis (80%), granulomas (90%) and lytic necrosis (50%) ([Table II](#t02){ref-type="table"}).

The histopathological characteristics of the epidermis were much different between the secondary lesions and ulcers in DL. The ulcers presented higher frequencies of hyperkeratosis (90%), hydropic degeneration (70%) and spongiosis (80%) and lacked a fibrin crust. The papules presented a fibrin crust in 40% of the cases and presented acanthosis in 70% of the cases. Exocytosis was equal between the ulcers and papules (50%). These differences were not observed in the dermis ([Table II](#t02){ref-type="table"}).

A higher percentage of inflammation was observed in the LCL-L group (37 ± 10) compared with recent lesions (23 ± 13) ([Fig. 1A](#f01){ref-type="fig"}). We evaluated the time and extent of the lesion area and found that the lesions increased with disease progression only in the more advanced ulcers (over 30 days) (data not shown).

Fig. 1A: inflammation percentage in lesions from localised cutaneous leishmaniasis (LCL) and disseminated leishmaniasis (DL). Mean ± standard deviation (SD) are indicated; B: number of CD4^+^ T lymphocytes in lesions from LCL and DL. Mean ± SD are indicated; C: linear correlations of Spearman (p = 0.003; R = 0.92) between inflammation (%) and CD4^+^ T lymphocytes in recent (LCL-E) group; D: linear correlations of Spearman between inflammation (%) and CD4^+^ T lymphocytes in DL with papule (DL-P) group (p = 0.03; R = 0.44) (10 patients per group). Significance levels are indicated. DL-U: DL with ulcers; LCL-L: late LCL.

The primary and secondary lesions of patients with DL had various degrees of inflammation. The ulcerated lesions (DL-U) had a higher inflammatory infiltrate (35 ± 12) compared with the papular lesions (DL-P) (20 ± 12) ([Fig. 1A](#f01){ref-type="fig"}). Although the ulcerated lesions of this group were present for a similar time as the LCL-L lesions (over 30 days), there was no correlation with lesion area, as observed in the other group (data not shown). The area of the papules was not measured.

The presence of CD4^+^ T lymphocytes, although not statistically significant, was higher in the late ulcers than in the recent ulcers ([Figs 1B](#f01){ref-type="fig"}, [2A](#f02){ref-type="fig"}). A comparison between the number of CD4^+^ cells and the level of inflammation showed that the amount of CD4^+^ cells increased with the inflammatory infiltrate in early ulcers ([Fig. 1C](#f01){ref-type="fig"}). In later lesions, no correlation between CD4^+^ cells and inflammation was observed (data not shown). In DL, CD4^+^ T lymphocytes were more prevalent in ulcers than in papules ([Fig. 1B](#f01){ref-type="fig"}). Unlike the ulcers, the papules showed a positive correlation between the number of CD4^+^ lymphocytes and the extent of the inflammatory infiltrate ([Fig. 1D](#f01){ref-type="fig"}).

Fig. 2A: immunostained CD4^+^ T cells (400X) (arrows); B: immunostained CD68^+^ cells (400X) (arrows); C: immunostained CD20^+^ cells (400X) (arrows); D: in haematoxylin and eosin, the presence of plasma cells in the inflammatory infiltrate (arrowheads) (400X).

Macrophages were the most prevalent cell type and showed similar frequencies between LCL-L and LCL-E ([Figs 2B](#f02){ref-type="fig"}, [3A](#f03){ref-type="fig"}). Unlike the CD4^+^ T lymphocytes, the number of CD68^+^ macrophages in the inflammatory infiltrate progressively increased as inflammation increased, in both types of lesions ([Fig. 3B](#f03){ref-type="fig"}, [C](#f03){ref-type="fig"}). In DL biopsies, CD68^+^ cells were slightly higher in the ulcerated lesions than in the papules ([Fig. 3A](#f03){ref-type="fig"}). Unlike what was observed for LCL lesions, the presence of macrophages did correlate with increased inflammatory infiltrate in the DL lesions (data not shown).

Fig. 3A: number of CD68^+^ macrophages in lesions from localised cutaneous leishmaniasis (LCL) and disseminated leishmaniasis (DL). Mean ± standard deviation are indicated; B: linear correlations of Spearman between inflammation (%) (p = 0.0005; R = 0.89) and CD68^+^ macrophages recent LCL (LCL-E) group; C: linear correlations of Spearman (p = 0.01; R = 0.59) between inflammation (%) and CD68^+^ macrophages in late LCL (LCL-L) group (10 patients per group). DL-P: DL with papules; DL-U: DL with ulcers.

CD20^+^ B cells and plasma cells ([Fig. 2C](#f02){ref-type="fig"}, [D](#f02){ref-type="fig"}) in the LCL-L and LCL-E groups were similar and appeared more frequently in the late lesions ([Fig. 4](#f04){ref-type="fig"}). In DL, the CD20^+^ B lymphocytes were present in the same amount in the ulcers and papules. Although not significant, plasma cells tended to be more frequent in DL ulcers ([Fig. 4A](#f04){ref-type="fig"}, [B](#f04){ref-type="fig"}). The number of CD20^+^ B and plasma cells did not correlate with inflammatory infiltration in any of the four lesions evaluated (data not shown)

Fig. 4A: number of CD20^+^ B lymphocytes in lesions from localised cutaneous leishmaniasis (LCL) and disseminated leishmaniasis (DL). Mean ± standard deviation (SD) are indicated; B: number of plasma cells in lesions from LCL and DL. Mean ± SD are indicated (10 patients per group). Significance levels are indicated. DL-P: DL with papules; DL-U: DL with ulcers.

Neutrophils were rarely found in the tissues and appeared in equal numbers in all groups ([Fig. 5A](#f05){ref-type="fig"}, [B](#f05){ref-type="fig"}). However, in the early phase of ulcers, neutrophils appeared to be gradually recruited and correlated with increased inflammatory infiltrate; this did not occur in the older ulcers ([Fig. 5C](#f05){ref-type="fig"}). However, the number of neutrophils did not correlate with lesion duration (data not shown). Neutrophils were also rare in DL ([Fig. 5B](#f05){ref-type="fig"}). Neutrophils appeared to be important during the initial stage of the disease, but their numbers did not correlate with lesion progression or increased infiltration in biopsies (data not shown).

Fig. 5A: in haematoxylin and eosin, the presence of neutrophils in the inflammatory infiltrate (arrows) (400X); B: number of neutrophils in lesions from localised cutaneous leishmaniasis (LCL) and disseminated leishmaniasis (DL); C: linear correlations of Pearson between inflammation (%) and neutrophils in recent LCL (LCL-E) group (10 patients per group). DL-P: DL with papules; DL-U: DL with ulcers.

DISCUSSION
==========

The analysis of biopsies showed minimal differences in histology between the clinical forms of CL. Studies that have analysed different clinical forms and biopsies before and after treatment of recurrent CL lesions also did not observe any differences ([@B16], [@B25]). The frequency of morphological characteristics in the early and late LCL lesions is consistent with those described by [@B22] and by [@B42]. The differences observed at the epidermis in the biopsies from the DL patients were described in the first study on the histology of DL lesions ([@B8]). Therefore, it is not possible to establish an exact time of evolution of a CL lesion using histopathology and we cannot predict whether this lesion may progress or be cured.

The immune response mediated by T cells with a Th1 or Th2 profile in leishmaniasis has been well described based on findings from peripheral blood cells ([@B31], [@B11], [@B32], [@B34], [@B6]). However, few studies have evaluated the response *in situ*([@B16], [@B30], [@B13], [@B6]) compared with the response in DL ([@B8], [@B37], [@B21]). Unlike studies based on peripheral blood cells ([@B16], [@B14], [@B6]), the analysis of cells *in situ* made it possible to describe a different immune response pattern ([@B38], [@B6]).

By comparing the inflammatory infiltrates, we found that the late ulcers and the DL ulcers had higher inflammation than the early ulcers or papules. Thus, as the disease progresses, there is a continuous influx of inflammatory cells into the tissues and many inflammatory cells remain at the site of infection.

The abundance of CD4^+^ Th1 cells may be responsible for the development of immunity and for the natural healing of lesions ([@B38]). In biopsies of older ulcers from LCL and DL patients, there was a higher frequency of CD4^+^ T cells than in the early lesions and papules; these data are consistent with previous studies ([@B30], [@B13]). The early lesions and papules, unlike late and disseminated ulcers, demonstrated a positive correlation between the CD4^+^ cells and the amount of inflammatory cell infiltration, suggesting that during the early development of the disease, the recruitment of CD4^+^ cells occurs gradually. However, no association with the extent of inflammation and these cells was found in the late lesions. This may indicate a change to a lesion-healing phase.

Similar numbers of macrophages were observed in both stages of LCL and in the two clinical forms, but there was a slight tendency for increased numbers of macrophages in DL lesions; this predominance was also observed by [@B40]. Macrophages were the cell type that showed the strongest correlation with inflammation in LCL.

Little has been reported about B cells and antibodies in CL patients. Like the study by [@B40], our findings revealed that late LCL lesions had a higher frequency of B lymphocytes than early lesions. Higher production of IFN-γ is associated with increased antibody secretion by B cells, helping to contain the parasites, but IFN-γ is also associated with *Leishmania* entry into macrophages, a process that results in permanent lesions ([@B40]). Increased levels of antibodies in the blood have been associated with dissemination to the mucosa in patients with LCL ([@B8]). Similar numbers of B cells in ulcers and papules may be associated with the dissemination of the parasite. Because of the differences in the immune responses of DL patients, B cells may be more closely related to parasite spreading in these cases. However, in LCL, B cells may contribute more to persistent lesions. A new class of B cells capable of acting as regulatory cells (Bregs) has been studied in chronic and autoimmune diseases ([@B43], [@B7], [@B17]). An evaluation of the number of Breg cells in lesions from DL may show that Breg cells also enable the spread of *Leishmania*.

Plasma cells were frequently observed in the infiltrates of tissue lesions in all of the groups and they were more common than B lymphocytes in the LCL and DL late ulcerative lesions; this observation is consistent with previous studies showing that most of these cells are mature at the lesion site and are responsible for immunoglobulin production *in situ* ([@B23], [@B16], [@B40]). In contrast to CD4^+^ T lymphocytes, the recruitment of B lymphocytes and plasma cells did not occur gradually with disease progression in any clinical form. CD4^+^ T cells may play a role in inflammation, while B and plasma cells are coordinated differently.

Neutrophils were rare compared with the other cells analysed in this study and were present at similar numbers in all types of lesions. Several studies have evaluated neutrophils in leishmaniasis, especially in the early phase of the disease. However, some of the reports are controversial. For example, neutrophils may contribute to protection from the disease, but may also be important for the immunopathology ([@B29], [@B2], [@B20], [@B41], [@B1], [@B12]). Some studies have suggested that *Leishmania* can use neutrophils to invade macrophages during the initial attempt of these cells to contain the parasite ([@B2], [@B39]). However, [@B12] reported that neutrophils are recruited gradually during the initial phase and that their presence at the late stage occurs after the rupture of phagocytes filled with amastigotes, thus restarting an acute reaction in which neutrophils limit the disease progression ([@B12]). These data explain the positive correlation between early LCL and inflammatory infiltrate and the absence of a correlation with late lesions.

The tissues of ulcers from both clinical forms are similar and it is not possible to predict disease dissemination. The early ulcers and papules also showed some histopathological similarities. Although these two clinical forms are similar, they represent distinct immunological moments. The analysis of the dynamics of cellular infiltration into CL lesions in its various clinical forms contributes to the characterisation of the local inflammatory response and provides a better understanding of the pathogenesis of the disease.
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[^1]: DL: disseminated leishmaniasis; DL-P: DL with papules; DL-U: DL with ulcers; LCL: localised CL; LCL-E: recent LCL; LCL-L: late LCL; MST: Montenegro skin test; NM: not measured; SD: standard deviation.

[^2]: DL-P: DL with papules; DL-U: DL with ulcers; LCL: localised CL; LCL-E: recent LCL; LCL-L: late LCL; NS: not significant.
